For example, CD146+ CAFs have been identified as tumor-suppressive subsets in breast cancer, with high levels of CD146+ CAFs increasing the sensitivity of breast cancer to treatment (Brechbuhl et al., 2017). Here, MCAM is linked to breast carcinoma.